Delays - Progression of CKD without deteriorating nutritional status1
Decreases - Serum phosphorous levels & thus delays the occurrence of secondary hyperhyperparathyroidism and renal osteodystrophy2
Maintains - Nutritional status of the patients2
Long term co-administration of KA, EPO & LPD is associated with a delay in progression of renal insufficiency & reduction in proteinuria3